Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$775.1M
+109.2% from 2023
Prescriptions
53K
$14,749.11 per claim
Patients
8,777
5,712 prescribers
Total spending, 2024
$775.5M
$88,304.91 per patient
Medicare prescription drug plans paid $775.1M for Kisqali in 2024, for 52,552 prescriptions and refills to 8,777 patients (up 109.2% from 2023). The average cost per claim was $14,749.11.
California had the highest Medicare cost for Kisqali in 2024: $112.5M for 7,771 claims, followed by Texas ($54.0M).
Boris Bagdasarian, hematology-oncology in Glendale, CA, had the highest Medicare cost for Kisqali in 2024: 113 claims costing $1.7M.
Kisqali is made by Novartis AG (NVS), listed in the Medicare spending data as Novartis.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Boris Bagdasarian Glendale, CA | Hematology-Oncology | 113 | 20 | $1.7M |
| Antoine E Chahine Canfield, OH | Medical Oncology | 102 | Under 11 | $1.7M |
| Eugenio G Galindo |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 1,866 | 11,958 | 2,108 | $166.3M |
| 2023 | 3,573 | 24,572 | 4,536 | $370.5M |
| 2024 | 5,712 | 52,552 | 8,777 | $775.1M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Hematology-Oncology |
| 108 |
| 16 |
| $1.5M |
| Lindsey H Prochaska Wilmington, NC | Hematology-Oncology | 99 | 18 | $1.4M |
| Elquis M Castillo Gadsden, AL | Medical Oncology | 110 | 16 | $1.4M |
| Maroun E Hayek Greenville, MS | Hematology-Oncology | 83 | Under 11 | $1.3M |
| Melanie Clark Fort Wayne, IN | Hematology-Oncology | 100 | 14 | $1.3M |
| Nikita C Shah Orlando, FL | Hematology-Oncology | 89 | 12 | $1.3M |
| Bryan Lee Springfield, MA | Hematology-Oncology | 74 | Under 11 | $1.2M |
| Douglas E Merkel Evanston, IL | Medical Oncology | 74 | Under 11 | $1.2M |
| Wajeeha Razaq Oklahoma City, OK | Hematology-Oncology | 95 | 12 | $1.2M |
| Ines J Sanchez-Rivera El Paso, TX | Medical Oncology | 63 | Under 11 | $1.2M |
| Karo K Arzoo Burbank, CA | Hematology-Oncology | 68 | Under 11 | $1.2M |
| Melody Cobleigh Chicago, IL | Medical Oncology | 83 | 12 | $1.2M |
| Vir K Nanda Victorville, CA | Hematology-Oncology | 72 | Under 11 | $1.1M |
| Kumar Abhishek Mechanicsville, VA | Hematology-Oncology | 67 | Under 11 | $1.1M |
| Virginia Kaklamani San Antonio, TX | Medical Oncology | 63 | 11 | $1.1M |
| Philomena F McAndrew Beverly Hills, CA | Hematology-Oncology | 73 | 12 | $1.1M |
| Qamar J Khan Westwood, KS | Hematology-Oncology | 65 | 12 | $1.0M |
| Rowena D Meyer Duarte, CA | Nurse Practitioner | 72 | Under 11 | $1.0M |
| Nagaprasad Nagajothi Massillon, OH | Hematology-Oncology | 64 | 12 | $1.0M |
| Matthew Tipping Gold Beach, OR | Hematology-Oncology | 67 | 12 | $1.0M |
| Mary H Hackney Richmond, VA | Hematology-Oncology | 61 | Under 11 | $996K |
| Santa M Merle Guaynabo, PR | Hematology-Oncology | 62 | Under 11 | $993K |
| Girish C Kunapareddy Terre Haute, IN | Hematology-Oncology | 72 | 14 | $985K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Novartis NVS | 52,578 | $775.5M |